This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022. https://doi.org/10.1038/s41380-022-01661-0.
Cowen PJ, Browning M. What has serotonin to do with depression? World Psychiatry. 2015;14:158–60.
Beliveau V, Ozenne B, Strother S, Greve DN, Svarer C, Knudsen GM, et al. The structure of the serotonin system: a PET imaging study. NeuroImage. 2020;205:116240.
Erritzoe D, Godlewska BR, Rizzo G, Searle GE, Agnorelli C, Lewis Y, et al. Brain serotonin release is reduced in patients with depression: a [11c]cimbi-36 pet study with a d-amphetamine challenge. Biol Psychiatry. 2022:S0006322322017048.
Murakami M, Mainen ZF. Preparing and selecting actions with neural populations: toward cortical circuit mechanisms. Curr Opin Neurobiol. 2015;33:40–46.
Disner SG, Beevers CG, Haigh EAP, Beck AT. Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci. 2011;12:467–77.
Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. AJP. 2004;161:1256–63.
Godlewska BR, Browning M, Norbury R, Cowen PJ, Harmer CJ. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Transl Psychiatry. 2016;6:e957.
Lan DCL, Browning M. What can reinforcement learning models of dopamine and serotonin tell us about the action of antidepressants? Comput Psychiatry. 2022;6:166–88.
Seymour B, Daw ND, Roiser JP, Dayan P, Dolan R. Serotonin selectively modulates reward value in human decision-making. J Neurosci. 2012;32:5833–42.
Cools R, Nakamura K, Daw ND. Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacol. 2011;36:98–113.
Worbe Y, Palminteri S, Savulich G, Daw ND, Fernandez-Egea E, Robbins TW, et al. Valence-dependent influence of serotonin depletion on model-based choice strategy. Mol Psychiatry. 2016;21:624–9.
Pike AC, Robinson OJ. Reinforcement learning in patients with mood and anxiety disorders vs control individuals: a systematic review and meta-analysis. JAMA Psychiatry. 2022;79:313–22.
Huys QJ, Pizzagalli DA, Bogdan R, Dayan P. Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis. Biol Mood Anxiety Disord. 2013;3:12.
Michely J, Eldar E, Erdman A, Martin IM, Dolan RJ. Serotonin modulates asymmetric learning from reward and punishment in healthy human volunteers. Commun Biol. 2022;5:812.
Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW, et al. Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology. 2010;35:1290–301.
Frey A-L, McCabe C. Effects of serotonin and dopamine depletion on neural prediction computations during social learning. Neuropsychopharmacol. 2020;45:1431–7.
Scholl J, Kolling N, Nelissen N, Browning M, Rushworth MFS, Harmer CJ. Beyond negative valence: 2-week administration of a serotonergic antidepressant enhances both reward and effort learning signals. PLoS Biol. 2017;15:e2000756.
Langley C, Armand S, Luo Q, Savulich G, Segerberg T, Søndergaard A, et al. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacology. 2023. https://doi.org/10.1038/s41386-022-01523-x. 23 January 2023
Anderson RJ, Hoy KE, Daskalakis ZJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections. Clin Neurophysiol. 2016;127:3394–405.
Celada P, Puig MV, Artigas F. Serotonin modulation of cortical neurons and networks. Front Integr Neurosci. 2013;7:25.
Hahn A, Wadsak W, Windischberger C, Baldinger P, Höflich AS, Losak J, et al. Differential modulation of the default mode network via serotonin-1A receptors. Proc Natl Acad Sci USA. 2012;109:2619–24.
Wise T, Marwood L, Perkins AM, Herane-Vives A, Joules R, Lythgoe DJ, et al. Instability of default mode network connectivity in major depression: a two-sample confirmation study. Transl Psychiatry. 2017;7:e1105.
Sibon I, Strafella AP, Gravel P, Ko JH, Booij L, Soucy JP, et al. Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-αMtrp trapping. NeuroImage. 2007;34:1658–64.
Baeken C, De Raedt R, Bossuyt A, Van Hove C, Mertens J, Dobbeleir A, et al. The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression. Brain Stimul. 2011;4:104–11.
Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, et al. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry. 2013;18:93–100.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357–66.
Leucht S, Helfer B, Gartlehner G, Davis JM. How effective are common medications: a perspective based on meta-analyses of major drugs. BMC Med. 2015;13:253.
Turner EH, Cipriani A, Furukawa TA, Salanti G, de Vries YA. Selective publication of antidepressant trials and its influence on apparent efficacy: updated comparisons and meta-analyses of newer versus older trials. PLoS Med. 2022;19:e1003886.
Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387:1637–48.
Acknowledgements
CJH is supported by the Oxford Health NIHR Biomedical Research Centre. In the last 3 years PBF is supported by a National Health and Medical Research Council of Australia Investigator grant (1193596). The other authors report no source of funding or financial support to declare.
Funding
CJH has received consultancy payments from P1vital, Lundbeck, Zogenix, J&J, Medscape and Compass Pathways. She holds current grants from UCB, J&J and Pfizer. PBF has received equipment for research from Neurosoft, Nexstim and Brainsway Ltd. He has served on scientific advisory boards for Magstim and LivaNova and received speaker fees from Otsuka. He has also acted as a founder and board member for TMS Clinics Australia and Resonance Therapeutics. The other authors have no financial disclosures or conflicts of interest to declare.
Author information
Authors and Affiliations
Contributions
DA developed the idea and wrote the first draft. TW, PBF, CJH contributed to the conceptualisation of the article and the writing of the subsequent versions of the manuscript. All authors approved the final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arnone, D., Wise, T., Fitzgerald, P.B. et al. The involvement of serotonin in major depression: nescience in disguise?. Mol Psychiatry 29, 200–202 (2024). https://doi.org/10.1038/s41380-024-02459-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-024-02459-y
This article is cited by
-
Difficult lives explain depression better than broken brains
Molecular Psychiatry (2024)